Cabozantinib User Reviews & Ratings (Page 2)
Brand names: Cabometyx, Cometriq
Cabozantinib has an average rating of 6.7 out of 10 from a total of 25 reviews on Drugs.com. 58% of reviewers reported a positive experience, while 21% reported a negative experience.
Reviews for Cabozantinib
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about cabozantinib
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Cabometyx (cabozantinib) for Renal Cell Carcinoma "Mixed results on multiple mets, some higher ratings while some lower on SUV. No further progression following 4 months of therapy. Major side effects: diarrhea and minor increase in blood pressure."